Nova Mentis Life Science (Nova Mentis Life Science) Net Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Nova Mentis Life Science Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Nova Mentis Life Science's Net Income for the three months ended in Mar. 2024 was $-0.11 Mil. Nova Mentis Life Science's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, Nova Mentis Life Science's net margin for the quarter that ended in Mar. 2024 was 0.00%.

The historical rank and industry rank for Nova Mentis Life Science's Net Margin % or its related term are showing as below:

NMLSF' s Net Margin % Range Over the Past 10 Years
Min: -229390.91 Med: -124681.17 Max: -1171.43
Current: -1171.43

NMLSF's Net Margin % is ranked worse than
75.64% of 1018 companies
in the Biotechnology industry
Industry Median: -150.095 vs NMLSF: -1171.43

Nova Mentis Life Science Net Margin % Historical Data

The historical data trend for Nova Mentis Life Science's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Mentis Life Science Net Margin % Chart

Nova Mentis Life Science Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Margin %

Get a 7-Day Free Trial

-21,240.00

-218,877.78

Nova Mentis Life Science Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Mar24
Net Margin %	Get a 7-Day Free Trial															-	-	-	-647.62	-

Competitive Comparison of Nova Mentis Life Science's Net Margin %

For the Biotechnology subindustry, Nova Mentis Life Science's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Mentis Life Science's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nova Mentis Life Science's Net Margin % distribution charts can be found below:

* The bar in red indicates where Nova Mentis Life Science's Net Margin % falls into.

Nova Mentis Life Science Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Nova Mentis Life Science's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin	=	Net Income (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-1.815	/	0
	=	%

Nova Mentis Life Science's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.106	/	0
	=	%

Nova Mentis Life Science (OTCPK:NMLSF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Nova Mentis Life Science Net Margin % Related Terms

Thank you for viewing the detailed overview of Nova Mentis Life Science's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Mentis Life Science (Nova Mentis Life Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nova Mentis Life Science Corp (OTCPK:NMLSF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

HN3Q:Germany NOVA:Canada

Address

700-838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6

Website

https://www.novamentis.ca

Nova Mentis Life Science Corp is a Canadian-based biotechnology company. It is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova uses psilocybin in the treatment of Fragile X Syndrome (FXS). The company's goal is to diagnose and treat debilitating chronic conditions that have unmet medical needs such as autism spectrum disorder (ASD) and FXS. It has one industry segment, being research and development of psilocybin, and in one geographic area, which is Canada.